<DOC>
	<DOCNO>NCT00703430</DOCNO>
	<brief_summary>Alzheimer 's disease ( AD ) , associate behavioral disturbance approximately 50 % AD patient Beijing . Agitation , aggression specifically , consider serious noncognitive symptom experience patient dementia . Memantine recognize treatment Alzheimer 's disease either alone combination cholinesterase inhibitor . Its efficacy vascular dementia also establish . Family member continue play central role home care demented elderly China . This proposal conduct study Beijing , China investigate efficacy safety Memantine treatment agitation aggression AD patient . In addition , proposal aim explore impact memantine caregiver burden AD patient Chinese culture .</brief_summary>
	<brief_title>Memantine Aggression Agitation Alzheimer 's Disease ( AD )</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>1 . Written inform consent 2 . Clinical diagnosis Alzheimer 's disease . 3 . Having least minimum aggression score CohenMansfield Agitation Inventory ( CMAI ) : score â‰¥ 4 least 1 aggressive item , score 3 least 2 aggressive item , score 2 least 3 aggressive item , 2 aggressive item occur frequency 2 1 frequency 3 . 4 . Availability responsible family member carer ensure treatment compliance provide information informant assessment . 1 . Unavailability responsible family member carer 2 . Severe renal impairment . 3 . History seizures 4 . Diagnosis concomitant life threaten illness .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Alzheimer 's disease , agitation , aggression , dementia</keyword>
</DOC>